Stock listing
NASDAQ:PVLA Palvella Therapeutics, Inc. Stock
Home listing (NASDAQ) of Palvella Therapeutics, Inc.
Follow Palvella Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:PVLA
$123.92 USD +0.96 (+0.8%)
Close on Oct 20, 2026
- Day range
- $123.10 – $131.03 USDOct 20, 2026
- Volume
- 263,374 sharesOct 20, 2026
- Market cap
- $1.79B USDAt the close on Oct 20, 2026 · price × 14.41M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:PVLA · Home | $123.92 USD | +0.96 (+0.8%) | 263,374 | $123.30 | $131.03 | $123.10 | $122.96 | Close on Oct 20, 2026 |
| Frankfurt:PI6 | €109.00 EUR | +3.00 (+2.8%) | — | €109.00 | €109.00 | €109.00 | €106.00 | Close on Oct 20, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 20, 2026 · NASDAQ:PVLA · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $123.92 | +0.96 | +0.8% | $123.30 | $131.03 | $123.10 | 263,374 | |
| $122.96 | +2.66 | +2.2% | $121.93 | $125.08 | $120.75 | 271,658 | |
| $120.30 | -7.04 | -5.5% | $127.27 | $127.27 | $118.23 | 179,489 | |
| $127.34 | +4.76 | +3.9% | $123.58 | $129.49 | $122.51 | 240,969 | |
| $122.58 | -5.93 | -4.6% | $125.53 | $128.29 | $120.27 | 380,261 | |
| $128.51 | -5.87 | -4.4% | $134.08 | $134.14 | $127.97 | 215,834 | |
| $134.38 | -4.39 | -3.2% | $137.27 | $138.48 | $131.78 | 213,793 | |
| $138.77 | +7.43 | +5.7% | $130.70 | $139.86 | $128.80 | 174,040 | |
| $131.34 | +0.75 | +0.6% | $129.90 | $131.95 | $124.49 | 209,331 | |
| $130.59 | +2.59 | +2.0% | $125.97 | $131.35 | $125.00 | 152,000 | |
| $128.00 | -4.16 | -3.1% | $133.75 | $133.85 | $124.97 | 309,400 | |
| $132.16 | -0.31 | -0.2% | $132.50 | $133.27 | $129.51 | 140,600 | |
| $132.47 | -0.26 | -0.2% | $135.15 | $137.04 | $127.26 | 348,100 | |
| $132.73 | -5.20 | -3.8% | $135.57 | $139.23 | $131.65 | 337,400 | |
| $137.93 | -1.07 | -0.8% | $141.14 | $142.96 | $137.30 | 262,300 | |
| $139.00 | -0.83 | -0.6% | $140.20 | $141.54 | $136.18 | 214,800 | |
| $139.83 | +1.67 | +1.2% | $138.13 | $143.55 | $137.43 | 188,600 | |
| $138.16 | -7.91 | -5.4% | $147.02 | $147.44 | $137.86 | 193,300 | |
| $146.07 | -3.49 | -2.3% | $148.05 | $149.11 | $143.08 | 185,100 | |
| $149.56 | -8.57 | -5.4% | $157.62 | $157.62 | $147.43 | 180,600 | |
| $158.13 | +4.72 | +3.1% | $155.08 | $160.84 | $153.64 | 276,600 | |
| $153.41 | +2.85 | +1.9% | $152.40 | $155.11 | $151.31 | 123,600 | |
| $150.56 | -3.76 | -2.4% | $154.72 | $154.72 | $149.20 | 646,500 | |
| $154.32 | +2.89 | +1.9% | $154.78 | $156.79 | $151.55 | 152,800 | |
| $151.43 | +0.21 | +0.1% | $152.54 | $155.18 | $150.76 | 202,000 | |
| $151.22 | -0.47 | -0.3% | $152.72 | $155.63 | $148.15 | 215,600 | |
| $151.69 | +1.56 | +1.0% | $150.14 | $153.41 | $150.14 | 223,000 | |
| $150.13 | -0.26 | -0.2% | $152.75 | $154.30 | $149.98 | 163,300 | |
| $150.39 | -0.95 | -0.6% | $148.43 | $151.37 | $147.10 | 266,100 | |
| $151.34 | -0.94 | -0.6% | $147.26 | $155.00 | $145.91 | 149,400 | |
| $152.28 | -4.96 | -3.2% | $153.42 | $157.93 | $151.58 | 165,000 | |
| $157.24 | +1.77 | +1.1% | $152.95 | $157.45 | $152.95 | 162,300 | |
| $155.47 | +2.52 | +1.6% | $152.95 | $155.92 | $150.76 | 249,700 | |
| $152.95 | +2.40 | +1.6% | $153.76 | $157.00 | $149.68 | 125,200 | |
| $150.55 | -2.04 | -1.3% | $150.00 | $152.07 | $148.68 | 119,900 | |
| $152.59 | +2.62 | +1.7% | $147.95 | $152.89 | $143.47 | 245,800 | |
| $149.97 | -0.36 | -0.2% | $148.65 | $153.28 | $148.35 | 192,000 | |
| $150.33 | -4.00 | -2.6% | $154.04 | $156.04 | $149.04 | 232,800 | |
| $154.33 | +6.09 | +4.1% | $148.18 | $154.75 | $144.22 | 194,400 | |
| $148.24 | +2.49 | +1.7% | $148.59 | $151.54 | $145.14 | 191,989 | |
| $145.75 | +3.71 | +2.6% | $141.78 | $146.69 | $136.06 | 315,523 | |
| $142.04 | -0.54 | -0.4% | $145.55 | $146.92 | $138.54 | 161,900 | |
| $142.58 | -7.38 | -4.9% | $145.32 | $148.35 | $139.92 | 209,000 | |
| $149.96 | -0.46 | -0.3% | $156.77 | $157.07 | $142.12 | 217,200 | |
| $150.42 | -3.10 | -2.0% | $152.36 | $154.56 | $149.05 | 148,000 | |
| $153.52 | -2.61 | -1.7% | $154.39 | $157.65 | $152.33 | 187,000 | |
| $156.13 | -0.42 | -0.3% | $156.55 | $160.33 | $154.35 | 109,800 | |
| $156.55 | +1.48 | +1.0% | $156.00 | $158.87 | $150.41 | 243,200 | |
| $155.07 | +0.77 | +0.5% | $157.51 | $158.43 | $152.99 | 166,700 | |
| $154.30 | +2.08 | +1.4% | $154.05 | $156.78 | $152.78 | 188,407 | |
| $152.22 | -5.55 | -3.5% | $156.07 | $157.96 | $151.89 | 140,011 | |
| $157.77 | +2.84 | +1.8% | $159.00 | $160.21 | $156.09 | 182,300 | |
| $154.93 | +0.02 | 0.0% | $155.40 | $160.47 | $152.06 | 95,300 | |
| $154.91 | +2.92 | +1.9% | $155.25 | $157.98 | $151.11 | 147,300 | |
| $151.99 | +11.21 | +8.0% | $135.30 | $155.80 | $135.30 | 279,000 | |
| $140.78 | +1.74 | +1.3% | $138.06 | $142.62 | $135.32 | 145,900 | |
| $139.04 | -11.15 | -7.4% | $147.61 | $149.54 | $138.74 | 185,700 | |
| $150.19 | +7.59 | +5.3% | $144.50 | $150.78 | $143.80 | 157,700 | |
| $142.60 | -0.24 | -0.2% | $146.32 | $148.91 | $139.35 | 134,000 | |
| $142.84 | +1.07 | +0.8% | $142.28 | $146.80 | $137.74 | 148,600 | |
| $141.77 | +3.76 | +2.7% | $139.30 | $146.15 | $139.30 | 173,600 | |
| $138.01 | -5.195 | -3.6% | $144.45 | $144.45 | $136.68 | 184,300 | |
| $143.21 | +1.025 | +0.7% | $140.65 | $144.10 | $138.12 | 134,600 | |
| $142.18 | -1.76 | -1.2% | $142.19 | $143.58 | $139.02 | 143,600 | |
| $143.94 | +19.79 | +15.9% | $123.84 | $145.98 | $120.61 | 364,800 | |
| $124.15 | -33.09 | -21.0% | $155.72 | $157.55 | $123.97 | 558,100 |
- Ticker
- NASDAQ:PVLA
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 15, 2026
Palvella Therapeutics to Present Phase 3 SELVA and Phase 2 TOIVA Results, Along With New Pediatric Analyses, at 2026 PeDRA Annual Conference
Latest earnings call · Aug 4, 2026
Palvella Therapeutics (NASDAQ:PVLA) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Aug 4, 2026
Q2 2026 Earnings Presentation
Earnings · 25 slides
Calls
Replays
Palvella Therapeutics (NASDAQ:PVLA) Q2 2026 Earnings Call
Tue, Aug 04, 2026 · 8:30 AM ET
Watch TranscriptPalvella Therapeutics (NASDAQ:PVLA) Q1 2026 Earnings Call
Thu, May 07, 2026 · 8:30 AM ET
Watch TranscriptPalvella Therapeutics (NASDAQ:PVLA) Q4 2025 Earnings Call
Tue, Mar 31, 2026 · 8:30 AM ET
Watch Transcript
Latest news
Palvella Therapeutics to Present Phase 3 SELVA and Phase 2 TOIVA Results, Along With New Pediatric Analyses, at 2026 PeDRA Annual Conference
Oct 15, 2026
Closed $127.34 (+3.9%) on Oct 15, 2026
Palvella Therapeutics to Participate in the Chardan 10th Annual Healthcare Conference
Oct 13, 2026
Closed $128.51 (-4.4%) on Oct 13, 2026
Palvella Therapeutics Announces Three Poster Presentations Highlighting New Data in Microcystic Lymphatic Malformations and DSAP at Fall Clinical Dermatology 2026
Oct 12, 2026
Closed $134.38 (-3.2%) on Oct 12, 2026
U.S. Food and Drug Administration Awards Additional Funding for QTORIN™ Rapamycin for the Treatment of Microcystic Lymphatic Malformations
Sep 28, 2026
Closed $139.83 (+1.2%) on Sep 28, 2026
Palvella Therapeutics to Participate in Upcoming Healthcare Investor Conferences
Sep 2, 2026
Closed $152.95 (+1.6%) on Sep 2, 2026
Palvella Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference
Aug 5, 2026
Closed $154.91 (+1.9%) on Aug 5, 2026
Palvella Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Aug 4, 2026
Closed $151.99 (+8.0%) on Aug 4, 2026
Palvella Therapeutics Chief Scientific Officer Jeff Martini, Ph.D. Selected to Present at Upcoming FDA Public Workshop on Drug Repurposing
Jul 30, 2026
Closed $150.19 (+5.3%) on Jul 30, 2026
Palvella Therapeutics to Host Second Quarter 2026 Financial Results and Corporate Update Conference Call on August 4, 2026
Jul 28, 2026
Closed $142.84 (+0.8%) on Jul 28, 2026
Decks
Q2 2026 Earnings Presentation
Earnings · 25 slides · Aug 4, 2026
Investor Presentation (July 2026)
Investor deck · 61 slides · Jul 14, 2026
ISSVA World Congress 2026
Conference · 14 slides · May 20, 2026
Q1 2026 Earnings Presentation
Earnings · 30 slides · May 7, 2026
Palvella Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 45 in the last 12 months · 119 in all · newest Oct 15, 2026 · oldest 2021
- Calls
- 7 calls with a replay · 7 with a transcript · latest Aug 4, 2026
- Decks
- 23 decks · latest Aug 4, 2026
Where Palvella Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:PVLA · Home listing · This page | NASDAQ | United States | USD |
| gettex:PI6 | gettex | Germany | EUR |
| BOATS:PVLA | BOATS | United States | USD |
| Frankfurt:PI6 | Frankfurt | Germany | EUR |
| Munich:PI6 | Munich | Germany | EUR |
| Tradegate:PI6 | Tradegate | Germany | EUR |
| LS Exchange:A40RA6 | LS Exchange | Germany | EUR |
Log in to ask 6ix AI your own questions about Palvella Therapeutics, Inc.